Works matching IS 13524585 AND DT 2024 AND VI 30 AND IP 1

Results: 19

MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Yes.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 19, doi. 10.1177/13524585231222132

By:

Carnero Contentti, Edgar;
Wingerchuk, Dean M

Publication type:

Article

MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: No.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 21, doi. 10.1177/13524585231222140

By:

Marignier, Romain;
Cree, Bruce AC

Publication type:

Article

MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Commentary.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 23, doi. 10.1177/13524585231222131

By:

Weinshenker, Brian G

Publication type:

Article

Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 35, doi. 10.1177/13524585231213164

By:

Ladakis, Dimitrios C;
Reyes-Mantilla, Maria I;
Gadani, Sachin P;
Mace, Jackson W;
Dominguez-Penuela, Susana C;
Appiah, Mayaa J;
Smith, Matthew D;
Bhargava, Pavan;
Fox, Robert J;
Saidha, Shiv;
Calabresi, Peter A

Publication type:

Article

The Finger Dexterity Test: Validation study of a smartphone-based manual dexterity assessment.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 121, doi. 10.1177/13524585231216007

By:

Van Laethem, Delphine;
Denissen, Stijn;
Costers, Lars;
Descamps, Annabel;
Baijot, Johan;
Van Remoortel, Ann;
Van Merhaegen-Wieleman, Annick;
D'hooghe, Marie B;
D'Haeseleer, Miguel;
Smeets, Dirk;
Sima, Diana M;
Van Schependom, Jeroen;
Nagels, Guy

Publication type:

Article

Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 44, doi. 10.1177/13524585231212879

By:

Mattiesing, Rozemarijn M;
Kramer, Eline;
Strijbis, Eva MM;
Brouwer, Iman;
van Schijndel, Ronald A;
Gentile, Giordano;
Battaglini, Marco;
De Stefano, Nicola;
Uitdehaag, Bernard MJ;
Barkhof, Frederik;
Vrenken, Hugo;
Schoonheim, Menno M

Publication type:

Article

Deciphering prognostic indicators in AQP4-IgG-seropositive neuromyelitis optica spectrum disorder: An integrative review of demographic and laboratory factors.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 7, doi. 10.1177/13524585231212832

By:

Guo, Ruo-Yi;
Wang, Wen-Ya;
Huang, Jing-Ying;
Jia, Zhen;
Sun, Ya-Fei;
Li, Bin

Publication type:

Article

Stretching is not essential for managing MS spasticity: A randomized controlled trial.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 89, doi. 10.1177/13524585231215960

By:

Hugos, Cinda L;
Joos, Sandra K;
Perumean-Chaney, Suzanne E;
Cutter, Gary R;
Cameron, Michelle H

Publication type:

Article

Effectiveness of a blended booster programme for the long-term outcome of cognitive behavioural therapy for MS-related fatigue: A randomized controlled trial.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 71, doi. 10.1177/13524585231213258

By:

de Gier, Marieke;
Beckerman, Heleen;
Twisk, Jos WR;
Knoop, Hans;
de Groot, Vincent

Publication type:

Article

The disease-modifying therapy utilisation and cost trend for multiple sclerosis in Australia between 2013 and 2022.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 80, doi. 10.1177/13524585231213230

By:

Zhao, Ting;
Taylor, Bruce V;
Campbell, Julie A;
Palmer, Andrew J

Publication type:

Article

A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 63, doi. 10.1177/13524585231215268

By:

Dobson, Ruth;
Holden, David;
Vickaryous, Nicola;
Bestwick, Jonathan;
George, Katila;
Sayali, Tatiana;
Bianchi, Lucia;
Wafa, Mohammad;
Gold, Julian;
Giovannoni, Gavin

Publication type:

Article

A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 103, doi. 10.1177/13524585231214362

By:

Dalla Costa, Gloria;
Nos, Carlos;
Zabalza, Ana;
Buron, Mathias;
Magyari, Melinda;
Sellebjerg, Finn;
Guerrero, Ana Isabel;
Roselli, Lucia;
La Porta, Maria Libera;
Martinis, Matteo;
Bailon, Raquel;
Kontaxis, Spyridon;
Laporta, Estela;
Garcia, Esther;
Pokorny, Florian B;
Schuller, Björn W;
Folarin, Amos;
Stewart, Callum;
Leocani, Letizia;
Vairavan, Srinivasan

Publication type:

Article

A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 25, doi. 10.1177/13524585231214360

By:

Daboul, Lynn;
O'Donnell, Carly M;
Amin, Moein;
Rodrigues, Paulo;
Derbyshire, John;
Azevedo, Christina;
Bar-Or, Amit;
Caverzasi, Eduardo;
Calabresi, Peter A;
Cree, Bruce AC;
Freeman, Leorah;
Henry, Roland G;
Longbrake, Erin E;
Oh, Jiwon;
Papinutto, Nico;
Pelletier, Daniel;
Prchkovska, Vesna;
Raza, Praneeta;
Ramos, Marc;
Samudralwar, Rohini D

Publication type:

Article

Managing patients with late-onset neutropenia during treatment with ocrelizumab.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 134, doi. 10.1177/13524585231206219

By:

Wright, Sarah L;
Thompson, Alan J

Publication type:

Article

Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 131, doi. 10.1177/13524585231206218

By:

Beigneux, Ysoline;
Louapre, Celine;
Bihan, Kevin;
Roux, Thomas;
de Paz, Raphael;
Lubetzki, Catherine;
Maillart, Elisabeth

Publication type:

Article

Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 55, doi. 10.1177/13524585231201093

By:

Berek, Klaus;
Hegen, Harald;
Auer, Michael;
Barket, Robert;
Di Pauli, Franziska;
Hocher, Jakob;
Krajnc, Nik;
Zinganell, Anne;
Deisenhammer, Florian;
Berger, Thomas;
Bsteh, Gabriel

Publication type:

Article

Re-thinking race and geography in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 16, doi. 10.1177/13524585231205969

By:

Ontaneda, Daniel;
Amezcua, Lilyana

Publication type:

Article

Using instrumental variables to correct for bias in real-world cohort studies of the effects of disease-modifying treatment in MS.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 113, doi. 10.1177/13524585231201423

By:

Koch-Henriksen, Nils Iørgen;
Thygesen, Lau Caspar;
Sørensen, Per Soelberg;
Magyari, Melinda

Publication type:

Article

Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 3, doi. 10.1177/13524585231205970

By:

Yamout, Bassem I.;
Viswanathan, Shanthi;
Laurson-Doube, Joanna;
Sokhi, Dilraj

Publication type:

Article